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1. Introduction 
A protein phosphatase active on several substrates 
including phosphorylase a, glycogen synthase b, 
phosphorylase kinase, histone, the R subunit of cyclic 
AMP-dependent protein kinase, casein and troponin I, 
has been extracted from liver [l-4], muscle [4-71, 
heart [8,9], kidney and brain [4]. This so-called 
multifunctional protein phosphatase can be inhibited 
by two trypsin-sensitive polypeptides extracted from 
boiled tissue homogenates and called inhibitor 1 and 
inhibitor 2 [lo-161. Inhibitor 1 is active only when 
it has been phosphorylated by cyclic AMP-dependent 
protein kinase [ll]. Cohen et al. [17,18] proposed 
to use the property to be inhibited by inhibitor 2 
for the specific recognition of the multifunctional 
phosphatase, presently called ‘protein phosphatase I’
[18,19] and previously referred to as protein phos- 
phatase III [ 171. On this basis, these authors reported 
that 90% of the phosphorylase phosphatase and 
glycogen synthase phosphatase activity measured in a 
fresh muscle extract are catalyzed by this multi- 
functional protein phosphatase [171. 
In contrast with these findings, we have observed 
that in a fresh liver extract, phosphorylase phosphatase 
is insensitive to the heat-stable inhibitors. If, however, 
the extract was not kept strictly at 0°C or if it was 
incubated in the presence of trypsin, an enzyme which 
was highly sensitive to inhibitor 2 was formed [20]. 
The present work was therefore undertaken in order 
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to check if a similar situation exists in muscle. We 
report that the phosphorylase phosphatase present in 
a fresh muscle extract was not affected by concentra- 
tions of inhibitors 1 or 2 which inhibited by > 90% 
the same preparation when treated with trypsin. A 
partial activation of the inhibitor-sensitive protein 
phosphatase occurred during the prolonged centrifuga- 
tion which is the first step of several [4-7,211 
purification procedures. 
2. Materials and methods 
Male Wistar rats were killed by decapitation, male 
rabbits by cervical dislocation. Muscle of the hind 
limb was excised and placed in ice. The muscle was 
cut into small pieces and homogenized with an Ultra- 
Turrax (Janke und Kunkel, Staufen im Breisgau) for 
30 s (speed 7-8), in 3 vol. of an ice-cold solution 
containing 50 mM imidazol and 0.5 mM dithiothreitol 
(pH 7.4). The homogenate was centrifuged in the 
cold for 5 min at 12 000 rev./min (extract final temp. 
O’C) or 45 min at 6000 rev./min (final temp. 5-6°C) 
in a Sorvall centrifuge. It was verified that the super- 
natant protein concentration was the same in both 
procedures. The supernatant was passed through a 
Sephadex G-25 column equilibrated with the 
homogenization buffer. In some experiments, the 
muscle was homogenized in 3 vol. of a solution con- 
taining 4 mM EDTA and 15 mM &mercaptoethanol 
(pH 7), and the extract filtered on Sephadex 
equilibrated in 50 mM Tris-HCl, 1 mM EDTA, 
15 mM /3-mercaptoethanol as in [ 171; these experi- 
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ments yielded results undistingui~able from the 
others. The Sephadex filtrate was either used as such 
or diluted 3-fold with the buffer used for the filtration 
and mixed with trypsin added at final cont. 1.3 mg 
trypsin~ml and the mixture incubated for 15 min at 
room temperature. The reaction was stopped by 
addition of a 4-fold excess of soybean trypsin 
inhibitor. 
Phosphorylase phosphatase was measured as in 
[20]. One unit of phosphorylase phosphatase is the 
amount of enzyme which inactivates one unit of 
phosphorylase n per minute under our assay con- 
ditions. In most assays, 20-40 mU of enzyme were 
present in 0.1 ml total vol. Inhibitor 1 was prepared 
by the method in 1221, with some modifications. The 
rabbit muscle was minced, homogenized in 3 vol. of 
a solution containing 4 mM EDTA and 2% trichloro- 
acetic acid, and centrifuged for 5 min at 12 000 rev./ 
min. The pellet, containing in~bitor 2 [22], was 
discarded; the supernatant was incubated for 1.5 min 
in a boiling water bath and centrifuged for 5 min at 
12 000 rev./min. The supernatant was filtered on 
Sephadex G-25, equilibrated with 50 mM glycylglycine 
(pH 7.4). This filtrate was then incubated for 2 h at 
30°C with cyclic AMP-dependent protein kinase, 
0.01 mM cyclic AMP, 0.2 mM ATP, 2 mM Mg acetate 
[ 131. It was verified that a shorter incubation period 
yielded the same aInount of inhibitor, indicating that 
the phosphorylation was complete. To stop the reac- 
tion the mixture was immersed in a boiling water 
bath for 15 min and filtered on Sephadex G-25 in 
50 mM glycylgly~ine (pH 7.4). This preparation was 
stored at -20°C. As a control, the boiled extract was 
incubated 2 h at 3O*C, without any addition, boiled 
and filtered. No inhibition of trypsin-activated 
phosphorylase phosphatase was observed with the 
latter preparation, indicating that in~bitor 2 was 
absent. Cyclic AMP-dependent protein kinase (a gift 
of Dr G. van den Berghe) was purified from beef 
muscle [23 J. Inhibitor 2 was partially purified by the 
method in [ 171, up to and including the DEAE- 
ceilulose step, with the following rnodi~cations. The 
DEAE cellulose eluate was concentrated by Amicon 
filtration (PM 30), filtered on Sephadex G-25 
equilibrated in 50 mM glycylglycine (pH 7.4) and 
stored at -20°C. One unit of inhibitor 1 and 2 is the 
amount which causes a 50% inI~bition of the trypsin- 
activated phosphatase under our assay conditions. 
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3. Results 
Figure 1 and fig.2 show the sensitivity of various 
types of skeletal muscle phosphorylase phosphatase 
to inhibitor 1 and in~bitor 2, respectively. The 
phosphatase present in the trypsin-treated extract was 
the most sensitive and could be inhibited 100% by 
relatively low concentrations of both inhibitors. In 
contrast, the enzyme present in a fresh muscle extract, 
obtained by a 5 min centrifugation of the homogenate, 
was minimally affected. Indeed no inhibition was 
detected at concentrations of the inhibitors that 
brought about a 90% inhibition of the trypsin-treated 
enzyme. Acomplete inhibition was, however,observed 
at very high concentrations of inhibitor 2, to which 
the fresh enzyme was -7O- 1 OO-fold less sensitive 
than the trypsin-treated extract. The phosphatase 
present in an extract obtained by a more prolonged 
centrifugation displayed intermediary properties. The 
percent of inhibition of this type of enzyme was how- 
ever variable from one preparation to another. We 
have collected in table 1 the results obtained in 5 
different preparations in which the effect of both 
4 6 8 10 
Inhibitor 1 (units) 
Fig.1. Effect of inhibitor 1 on the activity of phosphorylase 
phosphatase in a rat muscle extract. The extract was obtained 
as in section 2 by a centrifugation of 5 mm (5 min extract) or 
of 45 min (45 min extract). A portion of the 5 min extract 
was further diluted 3-fold and treated with trypsin. 10 rl of 
each preparation conta~in~ about 25 mU of phosphoryla~ 
phosphatase was used for the assay. 
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Fig.2. Effect of inhibitor 2 on the activity of phosphorylase phosphatase in a rat muscle extract. Same procedure as in fig.l. 
~hibitors has been studied in parallel. It has also 
been observed on several occasions that the addition 
of 5 mM EGTA to the homogenization medium 
decreased the sensitivity of the extract o inhibitor 2 
(not shown). Erratic results were obtained with 
extracts prepared from frozen rabbit muscle. In some 
of these preparations, no phosphorylase phosphatase 
activity was detectable (not shown). 
Table 2 shows that a fresh muscle xtract has little 
if any inhibitory property on the phosphorylase 
~hosphatase present in a trypsin treated extract and 
that the in~bito~ property is revealed by heating the 
extract in a boiling water bath. 
4. Discussion 
From these results we conclude that the multi- 
functions, i~bitor-sensitive, protein phosphatase 
purified from various tissues (see section 1) is not 
present in a fresh muscle xtract. This enzyme is 
generated, pres~ably by proteolysis, during the 
Table 1 
Effect of inhibitors 1 and 2 on the activity of phosphorylase phosphatase present 
in a muscle extract 
Phosphorylase phosphatase (mu phosphorylase ~ct~ated/~n) 
5 min extract 4.5 min extract 
Addition: None Inhibitor 1 Inhibitor 2 None Inhibitor 1 inhibitor 2 
(4.5 IJ) (3 I.0 (4.5 v) (3 UI 
Rat 28 27 28 33 23 24 
Rat 19 18 18 17 10 10 
Rat 22 21 22 21 11 15 
Rabbit 24 25 25 42 28 2.5 
Rabbit 44 43 45 47 31 33 
General procedure as in fii.1. In each assay 10 #i extract was used in 0.1 ml totaI 
vol. [ 201. The amount of inhibitor added caused an -90% inhibition of the 
tips-activated enzyme (see f&1,2) 
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Table 2 
Inhibition of the trypsin-activated phosphorylase 
phosphatase by boiled and unboiled muscle extracts 
Muscle 
source 
Addition Phosphorylase phosphatase 
act. (% of theoretical) 
Rat (n = 4) 5 min extract 95 f 4.1 
Boiled extract 36 ? 3.5 
Rabbit (n = 3) 5 min extract 94 f 2.3 
Boiled extract 49 + 4.8 
A trypsin-activated extract (10 r.11) was incubated with an 
equivalent amount of the same extract not treated with 
trypsin and which has or has not been immersed for 15 min 
in a boiling water bath. The activities are expressed in percent 
of the theoretical value obtained by additioning the activity 
of the two components of the mixture, measured separately. 
Values shown are means k SEM 
prolonged centrifugation which is an early step in 
several published purification procedures [4-7,211. 
The situation in muscle resembles that described for 
the liver [20]. In the latter tissue, the native phospho- 
rylase phosphatase is not inhibited by heat-stable 
inhibitors. It is distinct from synthase phosphatase 
and is entirely bound to particulate glycogen. There is 
little or no phosphorylase phosphatase activity in a 
freshly prepared high-speed supernatant from liver, 
although a large activity can be generated from the 
same preparation upon trypsin treatment. This 
activity is highly sensitive to heat-stable inhibitors 
and obviously originates from a previously com- 
pletely inactive, latent, proenzyme, which is distinct 
from the native enzyme. Furthermore, the activation 
by trypsin was not entirely explained by the proteo- 
lytic destruction of the heat-stable inhibitors. The 
inhibitor-sensitive enzyme can also be formed by 
treatment with ethanol at 2O”C, a procedure initially 
introduced [ 1,2] for the purification of the liver 
enzyme and later on used to purify the heart enzyme 
[8,9]. Trypsin digestion has an effect similar to that 
of warm ethanol [20,24] and may be the simplest 
procedure to obtain from any tissue a protein 
phosphatase which is highly sensitive to heat-stable 
inhibitors. From these data we conclude that in the 
muscle, like in the liver, there is at present no proof 
that the multifunctional protein phosphatase plays a 
role in glycogen metabolism. Other roles have been 
recently proposed for this enzyme [ 181. 
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The physiological role of the heat-stable 
inhibitors also appears very problematic since not 
only do they have little activity on the native 
phosphorylase phosphatase, but also their efficiency 
is greatly increased by boiling the extract. The 
inhibition reported in table 2 is presumably 
attributable to both inhibitors, since inhibitor 1 is 
more abundant in muscle than inhibitor 2 [19] and 
is normally -3% in the phosphorylated form [22]. 
Figure 1 indicates that inhibitor 1 is apparently not 
rapidly dephosphorylated in the presence of a crude 
muscle extract since its activity was clearly apparent 
on unpurified preparations. 
Our data are also illustrative of the danger of 
drawing conclusions from the properties of purified 
enzymes which might be artefactually modified or 
generated during the purification procedure. 
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